NEWS.com.au SOME Alzheimer's drugs could reduce the risk of heart attacks and death, according to research. Scientists in Sweden studied over 7,000 people with the disea...
PressAndUpdate.com We already know that galantamine , an Alzheimer's drug recently approved in the US and in Europe, can improve learning, memory and the ability to carry out everyday tasks. Now it seems that the new medication may also put off the time when the patient ...
Toronto NewsFIX They were assigned to either galantamine or placebo for six months. During this time, the galantamine group improved in cognition and functioning, or remained stable, while those on placebo tended to deteriorate. Further research is needed, but the ...
The New York Academy of Sciences On May 6, 2013, the Academy's Brain Dysfunction Discussion Group, partnering with the Alzheimer's Drug Discovery Foundation, presented Translating Natural Products into Drugs for Alzheimer's and Neurodegenerative Disease. The symposium explored ... and more »
pharmabiz.com Namenda XR was studied in combination with commonly prescribed AChEIs ( donepezil , galantamine, or rivastigmine). “We are pleased to be introducing Namenda XR so that patients can benefit from the convenience of a once-daily regimen that aligns with ...
Jagran Post Professor Peter Nordstrom, of Umea University, Umea, Sweden, and colleagues reviewed records on 7,073 Alzheimer's patients taking cholinesterase inhibitors (ChEIs), such as Donepezil, Rivastigmine and Galantamine , which are used for treating mild to ...
